Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):320-4. doi: 10.1161/01.ATV.0000110444.59568.56. Epub 2003 Dec 4.

Abstract

Objective: Human insulin enhances the vasodilatory effect of acetylcholine (ACh), an endothelium-dependent vasodilator, in normal subjects. Structural changes in a long-acting insulin analog, insulin glargine, may change its binding properties to insulin receptor and structurally homologous receptors, such as the insulin-like growth factor-1 receptor, and thereby alter its vascular effects. In the present study, we compared effects of glargine and regular human insulin on blood flow responses to endothelium-dependent and endothelium-independent vasoactive agents in vivo in normal subjects.

Methods and results: Ten healthy men (age: 33+/-9 years [mean+/-SD]; BMI: 23+/-2 kg/m2) were studied on two separate occasions in a double-blind, randomized, crossover fashion. In each study, blood flow responses to intrabrachial artery infusions of ACh and SNP were determined during infusion of saline and intravenously maintained normoglycemic hyperinsulinemia. Hyperinsulinemia (120 minutes; infusion rate: 1 mU/kg per minute) was created by infusing either insulin glargine or human regular insulin. Glargine and human regular insulin similarly stimulated whole-body glucose metabolism and suppressed serum free-fatty acid (FFA) concentrations. Endothelium-independent blood flow responses to low (3 microg/min) and high (10 microg/min) doses of SNP were unaffected by insulin glargine (12.2+/-2.6 versus 13.4+/-4.6 and 19.1+/-4.2 versus 19.6+/-5.1 mL/dL per minute, saline versus insulin, low- and high-dose) and regular human insulin (11.2+/-3.4 versus 12.0+/-5.2 and 16.8+/-5.7 versus 18.4+/-7.7 mL/dL per minute, respectively). In contrast, endothelium-dependent blood flow responses to low (7.5 microg/min) and high (15 microg/min) doses of ACh increased significantly and similarly by insulin glargine, 13.9+/-4.8 versus 19.3+/-6.5 mL/dL per minute (saline versus insulin, +39%, P<0.01) for low-dose ACh and 17.3+/-6.3 versus 23.2+/-9.2 mL/dL per minute (+34%; P<0.02) for high-dose ACh, and regular human insulin, 11.5+/-6.0 versus 15.8+/-8.0 mL/dL per minute (+38%; P<0.05) and 14.0+/-7.5 versus 21.1+/-10.4 mL/dL per minute (+51%; P<0.01).

Conclusions: Insulin glargine and regular human insulin have similar acute stimulatory effects on endothelium-dependent vasodilation in humans.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / administration & dosage
  • Acetylcholine / metabolism
  • Acetylcholine / pharmacology
  • Adult
  • Blood Circulation / drug effects
  • Blood Circulation / physiology
  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Synergism
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology*
  • Epidural Space / blood supply
  • Epidural Space / metabolism
  • Fasting / blood
  • Fasting / physiology
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Humans
  • Infusions, Intra-Arterial / methods
  • Insulin / administration & dosage
  • Insulin / analogs & derivatives*
  • Insulin / pharmacology*
  • Insulin Glargine
  • Insulin, Long-Acting
  • Male
  • Nitroprusside / administration & dosage
  • Nitroprusside / metabolism
  • Nitroprusside / pharmacology
  • Vasodilation / drug effects*

Substances

  • Insulin
  • Insulin, Long-Acting
  • Nitroprusside
  • Insulin Glargine
  • Acetylcholine